SCHEMBL26641240

SCHEMBL26641240

O=C1CCN(c2ccc(N3CCN(C(=O)O)CC3)cc2Cl)C(=O)N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 5/20 0.43
▸ CRBN Q96SW2 5/20 0.43
▸ MAPT P10636 5/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GFER P55789 1/20 0.41
▸ HTT P42858 3/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ ADAMTS5 Q9UNA0 3/20 0.40
▸ LMNA P02545 2/20 0.39
▸ MMP2 P08253 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TNKS O95271 2/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ USP2 O75604 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30643667 0.84 DDB1 (0.49) DDB1CRBNMAPTSMN1; SMN2ALDH1A1
SCHEMBL26641815 0.83 ADRB1 (0.54) DDB1CRBNMAPTALDH1A1HTT
SCHEMBL29007105 0.82 CRBN (0.59) DDB1CRBNMAPTSMN1; SMN2ALDH1A1
SCHEMBL23983379 0.77 TYMP (0.39) DDB1CRBNMAPTALDH1A1HTT
SCHEMBL28978059 0.76 HPGD (0.44) DDB1CRBNSMN1; SMN2ALDH1A1LMNA
SCHEMBL23121262 0.75 CRBN (0.48) DDB1CRBNMAPTALDH1A1MEN1
SCHEMBL29607217 0.75 CRBN (0.48) DDB1CRBNMAPTALDH1A1MEN1
SCHEMBL23984161 0.75 LMNA (0.39) DDB1CRBNMAPTSMN1; SMN2ALDH1A1
SCHEMBL25666847 0.75 DDB1 (0.39) DDB1CRBNALDH1A1HTTADAMTS5
SCHEMBL631834 0.74 MAPT (0.68) MAPTSMN1; SMN2ALDH1A1GFERHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 — — WO disclosed
Send feedback